Truist Financial’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228K | Sell |
12,795
-1,921
| -13% | -$34.2K | ﹤0.01% | 2334 |
|
|
2025
Q1 | $262K | Buy |
14,716
+3,294
| +29% | +$58.7K | ﹤0.01% | 2193 |
|
|
2024
Q4 | $340K | Buy |
+11,422
| New | +$340K | ﹤0.01% | 2069 |
|
|
2023
Q3 | – | Sell |
-12,638
| Closed | -$524K | – | 2631 |
|
|
2023
Q2 | $524K | Buy |
12,638
+3,502
| +38% | +$145K | ﹤0.01% | 1918 |
|
|
2023
Q1 | $549K | Sell |
9,136
-2,443
| -21% | -$147K | ﹤0.01% | 1915 |
|
|
2022
Q4 | $849K | Buy |
11,579
+647
| +6% | +$47.5K | ﹤0.01% | 1631 |
|
|
2022
Q3 | $831K | Buy |
10,932
+1,530
| +16% | +$116K | ﹤0.01% | 1570 |
|
|
2022
Q2 | $653K | Buy |
+9,402
| New | +$653K | ﹤0.01% | 1743 |
|
|
2021
Q1 | – | Sell |
-1,993
| Closed | -$345K | – | 2675 |
|
|
2020
Q4 | $345K | Buy |
1,993
+121
| +6% | +$20.9K | ﹤0.01% | 2050 |
|
|
2020
Q3 | $208K | Buy |
+1,872
| New | +$208K | ﹤0.01% | 2212 |
|
|
2020
Q2 | – | Sell |
-5,432
| Closed | -$365K | – | 2499 |
|
|
2020
Q1 | $365K | Sell |
5,432
-3,540
| -39% | -$238K | ﹤0.01% | 1720 |
|
|
2019
Q4 | $756K | Buy |
+8,972
| New | +$756K | ﹤0.01% | 1579 |
|